Showing results (591-600 of 1,555) with videos related to
Sort By:
Pageof 156
JCO Oncology Practice|May 31, 2026
Impact of Dedicated Care Coordination on Access to Multidimensional Support Services in Young-Onset Colorectal Cancer: A Pragmatic TrialJeongyoon Moon, Elaine Maghanoy, Victoria S Higbie, et al.JCO Oncology Practice|February 10, 2021
Care Experience, by Site of Care, for Adolescents and Young Adults With CancerRebecca L Jacobsen, Catherine Fiona Macpherson, Bethann Mangel Pflugeisen, et al.JCO Oncology Practice|April 14, 2021
Disparities Between Provider Assessment and Documentation of Care Needs in the Care of Adolescent and Young Adult Patients With SarcomaGrace E McKay, Anna L Zakas, Fauzia Osman, et al.JCO Oncology Practice|August 18, 2022
Patient, Family, and Clinician Perspectives on Location of Death for Adolescents and Young Adults With CancerOreofe O Odejide, Lauren Fisher, Lawrence H Kushi, et al.JCO Oncology Practice|April 2, 2026
Implementing a System-Wide Comprehensive Cancer Navigation Program in a Rapidly Expanding Health SystemJulien T Hohenleitner, Shruti Koti, David Hyman, et al.JCO Oncology Practice|April 27, 2026
Attitudes, Practices, and Barriers to Spiritual Care for Patients With Cancer: An International SurveyCarla Ida Ripamonti, Junita Henry, Christina M Puchalski, et al.JCO Oncology Practice|April 29, 2026
Association Between Antibiotic Therapy and Treatment Effectiveness in Patients With Renal Cell Carcinoma Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase InhibitorsAvery E Braun, Hamed Hesami, Mengying Deng, et al.JCO Oncology Practice|April 23, 2026
Toward Sustainable Hematology/Oncology Fellowship Training Through Career-Aligned SpecializationRyan C Augustin, Alexandra P Wolanskyj-Spinner, Lori J Rosenstein, et al.JCO Oncology Practice|May 6, 2026
Survival, Toxicity, and Economic Outcomes of Osimertinib Versus Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung CancerPo-Huang Chen, Hong-Jie Jhou, Wei-Cheng Chang, et al.JCO Oncology Practice|May 4, 2026
Efficacy of Renin-Angiotensin System Inhibitors in Long-Term Oncologic Outcomes of Patients With Stage II/III Colon Cancer and Hypertension: A Target Trial EmulationKaiwen Chen, Donghao Xu, Zhiyuan Zhang, et al.Pageof 156